Background illustration for clinical trials search

Paid Clinical Trials Princeton

Discover 1,664 paid clinical trials in Princeton, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

for
Malignant Neoplasm
Location: New Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT06941272

Phase1, Phase2, Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: New Brunswick NJ, Hackensack NJ, Baltimore MD,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06966700

Phase3, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: New Brunswick NJ, Morristown NJ, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: New Brunswick NJ, Philadelphia PA, Brooklyn NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase2, Recruiting

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

for
Breast Neoplasms
Location: New Brunswick NJ, Hackensack NJ, Jamaica NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07060807

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

for
Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
Location: New Brunswick NJ, The Bronx NY, Hershey PA,
Sponsor: UroGen Pharma Ltd.

Sex: All

Age: 18+

Code: NCT06774131

Phase3, Recruiting

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

for
Bladder Cancer, Non-muscle Invasive Bladder Cancer
Location: New Brunswick NJ, Ann Arbor MI, Tampa FL, Vancouver
Sponsor: Photocure

Sex: All

Age: 18+

Code: NCT07144319

Recruiting

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

for
Mesothelioma, Non Small Cell Lung Cancer,
Location: New Brunswick NJ, New York NY, Mineola NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05245500

Phase1, Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: New Brunswick NJ, Somerville NJ, Flemington NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase2, Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: New Brunswick NJ, Pittsburgh PA, Philadelphia PA,
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 0+

Code: NCT01351545

Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: New Brunswick NJ, Newark NJ, Neptune City NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT06064097

Phase2, Recruiting

Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients

for
Non-Hodgkin's Lymphoma
Location: New Brunswick NJ, Baltimore MD, Bethesda MD, Boston MA,
Sponsor: Xcyte Therapies

Sex: All

Age: 18+

Code: NCT00081783

Phase2, Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for
Cutaneous Melanoma, Stage II
Location: Piscataway NJ, Philadelphia PA, Livingston NJ,
Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All

Age: 18+

Code: NCT03860883

Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia,
Location: New Brunswick NJ, Basking Ridge NJ, Middletown NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase2, Recruiting

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

for
cGVHD
Location: New Brunswick NJ, New York NY, Danville PA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05919511

Recruiting

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

for
Multiple Myeloma
Location: New Brunswick NJ, New York NY, Mineola NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05828511

Phase1, Phase2, Recruiting

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

for
Carcinoma, Non-small-Cell Lung
Location: New Brunswick NJ, Hackensack NJ, Baltimore MD,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05498428

Phase2, Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for
Biochemically Recurrent Prostate Carcinoma,
Location: New Brunswick NJ, Somerville NJ, Toms River NJ,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male

Age: 18+

Code: NCT04423211

Phase3, Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: New Brunswick NJ, Basking Ridge NJ, Middletown NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase2, Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

for
Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
Location: New Brunswick NJ, Philadelphia PA, Neptune City NJ,
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All

Age: 18+

Code: NCT04031677

Phase3, Recruiting